Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 4 Oct 22 EFFECT Notice of effectiveness
- 29 Sep 22 POS AM Prospectus update (post-effective amendment)
- 15 Aug 22 424B3 Prospectus supplement
- 28 Jun 22 424B3 Prospectus supplement
- 24 May 22 424B3 Prospectus supplement
- 30 Mar 22 424B3 Prospectus supplement
- 28 Feb 22 424B3 Prospectus supplement
- 14 Feb 22 424B3 Prospectus supplement
- 5 Jan 22 EFFECT Notice of effectiveness
- 4 Jan 22 424B3 Prospectus supplement
-
22 Dec 21 S-1 IPO registration
ROIV similar filings
Filing view
External links
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated June 30, 2021 (except Note 1(C), as to which the date is December 22, 2021) in the Registration Statement (Form S-1) and related Prospectus of Roivant Sciences Ltd. dated December 22, 2021.
/s/ Ernst & Young LLP
Iselin, New Jersey
December 22, 2021